ResMed (NYSE: RMD), a major player in respiratory care and digital health solutions, today announced a comprehensive brand evolution. This initiative aims to unify its brand portfolio and broaden its reach to better serve both patients and healthcare providers worldwide. The company, based in San Diego, is known for its leadership in sleep apnea treatment utilizing CPAP therapy, alongside its digital health offerings.
This evolution represents a significant step for ResMed, building on its previous brand update in 2014, which emphasized connectivity through cloud-enabled medical devices. The current transformation signals a shift into a “fully unified health technology brand,” according to the company. This new strategy allows ResMed to cater to millions of consumers, healthcare professionals, and software users worldwide, the company says.
“We are at a pivotal moment in health – sleep and breathing health are gaining the attention once reserved for diet and exercise, with consumers taking a more proactive role in their care,” stated Katrin Pucknat, ResMed’s Chief Marketing Officer. “Our brand evolution is more than a new look – it’s a bold step forward in our strategy to make sleep and breathing health a mainstream priority in global healthcare.”
As part of this brand evolution, ResMed plans to streamline its offerings by consolidating its various brands, products, and services under a single, unified brand identity. The goal is to provide a clearer and more accessible experience for both consumers and healthcare providers. Accompanying this change is a redesigned logo and a fresh visual identity.
ResMed also plans to launch its inaugural U.S. consumer campaign, designed to remove the stigma surrounding CPAP therapy and make sleep health more accessible and approachable. In addition, a targeted educational campaign for primary care physicians in the U.S. is designed to encourage earlier diagnosis and treatment of sleep apnea. The company is also running sleep health awareness campaigns in key markets across Asia Pacific and Europe.
“ResMed has evolved beyond its initial focus as a CPAP device and mask manufacturer. Our new brand reflects who we are today – a global leader in health technology, delivering solutions that help people rise to their full potential through better sleep and breathing, with care delivered in the home,” said Mick Farrell, ResMed Chair & CEO. “With this evolution, we are reaffirming our commitment to empowering 500 million people worldwide to achieve their full health potential by 2030 and changing the delivery of healthcare.”
